Komodo Drug ProjectionsA New Standard for Superior Projection
Real-world, real-time, real-simple: Access weekly, high-quality national projections for market baskets encompassing 10,000+ Rx and Mx benefit drugs and 3,000+ molecules via MapView’s™ no-code workflow.
Trusted and transparent: We bring together projected and observed data, confidence intervals, and time travel functionalities to provide deeper context and greater transparency into drug market share.
Data advantage: Leverage the power of Komodo’s Healthcare Map™ data foundation. Unlike traditional RX-only insights, our source selection, integration, characterization, and statistical modeling support a robust Projections model.
- Forthcoming releases: Stay ahead with our innovation roadmap featuring upcoming sub-national and compound Rx modeling capabilities to enhance your analytics.
Talk to an Expert
Helping the World’s Leading Companies
Transform Decision-Making With Solutions For Every Team
Investor Reporting
Leverage accurate forecasting in specialty and medical benefit drugs to provide leadership and investors with precise insights in a challenging market landscape.
Market Share Monitoring
Track market share and expected/projected market share at the brand and molecule level and identify gaps and areas of opportunity in complex markets.
Competitive Intelligence
Gain insights into competitive market share at the brand and molecule level to prioritize areas of focus, particularly in complex classes where therapies may be classified as Rx or Mx.
Market Sizing
Identify the most viable market opportunities to deploy resources and focus for maximum impact.
Launch Modeling
Construct launch curves to assess launch uptake for a new drug or indication based on relevant analogs.
Validation of Other Analyses
Use observed vs. projected data to confirm analysis in other MapView dashboard templates and other modeling tools.
Gain Your Velocity Advantage
It all starts with the right insights. Experience a higher evidentiary standard for your business.